Emma Murray

Goodwin

Contact
View Bio
RSS

Latest Posts › Celltrion

Share:

Updates on Aflibercept BPCIA Litigation

Emergency Motion for Entry of a PI Schedule Against Celltrion, Formcyon, and Samsung Bioepis - On December 28, Regeneron filed emergency motions for entry of a PI schedule in its aflibercept BPCIA cases against Celltrion,...more

1/8/2024  /  BPCIA , Celltrion , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Regeneron
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide